Wednesday, 22 December 2021

COVID-19: Oxford-AstraZeneca Begins Work on Omicron-Targeted Vaccine

The pharma giant AstraZeneca and Oxford University have come together to develop a COVID-19 vaccine that specifically targets the Omicron variant.


from Medindia Health News https://ift.tt/3picV3k

No comments:

Post a Comment